Neurology and Neurosurgery

Episodes 17-24 of 24

• 

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  MinuteCE®

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  MinuteCE®

  Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy

  1.00 credit 10 episodes

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 credit 10 episodes

• 

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  MinuteCE®

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  MinuteCE®

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  MinuteCE®

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  MinuteCE®

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  1.00 program credit

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credit

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit